Positive Impact

01424 851 375

Safe and effective heat therapy for the management of MGD


The use of heat is a well-established and important adjunct therapy in the management of meibomian gland dysfunction. As an Eye Care Professional your challenge is to deliver this therapy to your patients effectively and safely.

TearRestore Warm Compress gives you this reassurance.

TearRestore Warm Compress

TearRestore’s open-eye warm compress delivers an effective, user friendly at-home treatment for MGD. Developed with assistance from industry leading physicians, TearRestore delivers therapeutic heat where it is needed while allowing the patient to see throughout treatment.

TearRestore is the first open-eye warm compress that allows patients to be active during their treatment. The mask has specifically designed, reusable, heat packs that target the oil glands of the eyelid while avoiding the globes, permitting the user to blink throughout treatment resulting in natural oil gland expression.

Benefits of
TearRestore Warm Compress

Targeted treatment

It targets the Meibomian glands, resulting in natural oil gland expression throughout use.

Consistent Heat

Supplies therapeutic heat (>40C) for a minimum of ten minutes every use, ensuring effective treatment


The only open-eye warm compress that allows patients to be active during treatment


Symptom improvement


Tear breakup time

* Reference data below


Increase in Functional
Meibomian Glands

Find out more about TearRestore

Interested in using TearRestore Warm Compress in your practice?

Contact us to find out more about TearRestore and to order.

T: 01424 851 375

Read the news on
Positive Impact

Webinar: The Use of Heat in Managing MGD

Join Nick Atkins in this CPD webinar as he explores effective heat delivery options for managing MGD. Gain insights into both in-practice and at-home solutions to enhance your practice’s MGD management strategies.

Learn More
Two choices with easy empirical fitting

Positive Impact (PI) has launched two new contact lenses in the UK, Alexa high resolution AR, offering a…

Learn More
Our Annual Christmas Food Donation

In the true spirit of the season, we are thrilled to share a heartwarming tradition that has become…

Learn More


* Data was collected from a population of 22 eyes (age 18-89) of any race, gender or ethnicity, diagnosed with meibomian gland
dysfunction. Additional inclusion/exclusion criteria were applied. More information can be found at ClinicalTrials.gov